February « 2010 « ACTC.OB investor blog

These are the posts from February 2010

February 24, 2010
Posted by admin

Form 8-K for ADVANCED CELL TECHNOLOGY, INC.

ITEM 1.01 Entry into a Material Definitive Agreement.
On February 22, 2010, Advanced Cell Technology, Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement’) with William M. Caldwell, IV, who has been the Company’s chief executive office and chairman since January 2005. Pursuant to the Employment Agreement, the parties agreed as follows:
- Mr. Caldwell [...]

1 Comment

Posted Under Governance Stock Talk

February 23, 2010
Posted by admin

Seeking Alpha: “Updating, Advanced Cell Technology (OTCBB: ACTC)”

ACTC.OB appreciated (+ $0.014) 15.73 % on 2/22/10, with 18.5 M shares traded … after the National Institutes of Health (NIH) stated (over the weekend) that it was slightly expanding its definition for what constitutes a human embryonic stem cell as acceptable lines for federal funding. This NEW proposal will benefit several academic researchers and ACTC.OB, that has filed a request with [...]

1 Comment

Posted Under Stock Talk

February 19, 2010
Posted by admin

U.S. ‘tweaks’ stem cell policy

Dr. Robert Lanza of Massachusetts-based Advanced Cell Technology, one of the companies seeking federal funding for its research, said the decision was important.
Quoted from:
http://www.reuters.com/article/idCNN1919518220100219?rpc=44

No Comments

Posted Under Biotechnology Regenerative

February 16, 2010
Posted by admin

Research Featured in Scientific American, USA Today and Newsweek

Important Questions Raised about iPS cells, Reinforcing Unique Viability of ACT’s Blastomere Technology
WORCESTER, Mass.—(BUSINESS WIRE)—Advanced Cell Technology or “ACT” (OTCBB: ACTC – News announced today that its research involving therapeutic cell types obtained from induced pluripotent stem (iPS) cells has been featured in several leading news media outlets: Scientific American, USA Today and Newsweek. The coverage highlights [...]

2 Comments

Posted Under Biotechnology

February 11, 2010
Posted by admin

Therapeutic Cells Derived From iPS Cells Display Early Aging

Findings Support Use of ACT’s human embryonic stem cells
WORCESTER, MA –February 11, 2010 (PR Newswire). Advanced Cell Technology, Inc. or “ACT” (OTCBB: ACTC – News reported that a range of therapeutic cell types obtained from induced pluripotent stem (iPS) cells exhibit abnormal expansion and early cellular aging. The research, which appears online (published- ahead-of- print) in the [...]

No Comments

Posted Under Biotechnology